General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Enterococcus canis is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, oval-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 41.7-43.0%. Enterococcus canis is probably a rare gut coloniser. (Svec2011Bergey; DeGraef2003)



  • This organism has been recovered from dog faeces. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Can cause opportunistic infections, particularly in immunocompromised people. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Svec2011Bergey); (DeGraef2003);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin;
  • ±
  • Strain-dependent hydrolysis or digestion:
  • urea;
  • 🧂
  • Salt tolerance:
  • tolerates 6.5% salt;
  • 🌡
  • Temperature tolerance:
  • grows at 42℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; fructose; galactose; glucose; mannose; ribose; amygdalin; cellubiose; gentiobiose; lactose; maltose; glycerol; mannitol; arbutin; gluconate; 2-ketogluconate; N-Ac glucosamine;
  • ±
  • Strain-dependent acid from carbs:
  • D-arabinose; xylose; starch; sucrose; trehalose; α-methyl glucoside;
  • Substrates assimilated or utilised:
  • pyruvate;
  • Active enzymes:
  • acid phosphatase; α-glucosidase; β-glucosidase; Leu arylamidase; Phe arylamidase; pyrrolidine arylamidase; Val arylamidase;
  • ±
  • Strain-dependent active enzymes:
  • arginine dihydrolase; urease;

  • SPECIAL FEATURES (Svec2011Bergey); (DeGraef2003);
    Character Response
  • Metabolites produced:
  • lactate (major);
  • ±
  • VP test:
  • strain dependent
  • Haemolysis:
  • alpha
  • Pigments:
  • not produced

  • RESPONSE TO ANTIBIOTICS
    Class Active Resistant
  • Penicillins:
  • amoxicillin-clavulanic acid; piperacillin-tazobactam;
  • ertapenem;
  • Cephalosporins:
  • cefalexin;
  • Miscellaneous antibiotics:
  • clindamycin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Lactobacillales Family:  Enterococcaceae Genus:  Enterococcus Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Oval-shaped Pigment:  neg
    Health:  Unknown
    Source:  dog faeces
    DNA G+C(%):  41.7-43.0
    Opt. T:  37℃
    High T(℃):  42(+)
    NaCl >6%:  6.5(+)
    Aesculin:  + Urea:  d Starch:  neg Hippurate:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  d L-Arabinose:  + Fructose:  + Fucose:  neg D-Fucose:  neg Galactose:  + Glucose:  + Mannose:  + D-Lyxose:  neg Rhamnose:  neg Ribose:  + Sorbose:  neg D-Tagatose:  neg Xylose:  d L-Xylose:  neg Cellubiose:  + Gentiobiose:  + Lactose:  + Maltose:  + Melezitose:  neg Melibiose:  neg Sucrose:  d Trehalose:  d Turanose:  neg Amygdalin:  + Glycogen:  neg Inulin:  neg Starch:  d Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  + Mannitol:  + Sorbitol:  neg Xylitol:  neg Arbutin:  + Gluconate:  + 2-Ketogluconate:  + 5-Ketogluconate:  neg Me-α-D-Glc:  d Me-α-D-Mann:  neg NAc-α-GA:  +

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Pyruvate:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  d β-Galactosidase:  neg α-Glucosidase:  + β-Glucosidase:  + β-Glucuronidase:  neg ArgDH:  d LeuAA:  + PyrrolidAA:  + PheAA:  + ValAA:  + AlkalineP:  neg AcidP:  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Lactate:  Major(+) Pigment:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    Augmentin:  S(≤1/≤1)
    piper-taz:  S(≤2/>32)
    ertapenem:  R(8/16)
    cefalexin:  R(>32/>32)
    ciprofloxacin:  Var(MIC50): 1, MIC90: >8
    levofloxacin:  Var(MIC50): 1, MIC90: >8
    moxifloxacin:  Var(MIC50): 0.5, MIC90: >4
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  Var(MIC50): 4, MIC90: 8
    SXT:  Var(MIC50): ≤0.5, MIC90: 4
    clindamycin:  R(>8/>8)

    References


    SPECIFIC REFERENCES FOR ENTEROCOCCUS CANIS
  • Svec2011Bergey - Bergey's manual of systematic bacteriology. Vol. 3, The Firmicutes. Family Enterococcaceae, Genus I. Enterococcus
  • DeGraef2003 - Description of Enterococcus canis sp. nov. from dogs and reclassification of Enterococcus porcinus Teixeira et al. 2001 as a junior synonym of Enterococcus villorum Vancanneyt et al 2001.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR ENTEROCOCCUS CANIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................